Dana Hossieni

Dana Hosseini is the Chief Business Officer and Co-Founder of Seqster. Dana is a seasoned executive with decades of experience in the life sciences and CRO space and also as a serial entrepreneur having managed and co-founded a number of genomics-based companies including ProdermIQ, Iceland Genomics, and DiThera.

Dana has over 25 years of extensive experience helping pharma, biotech and CRO’s with development, clinical trial research and management, and patient engagement on a global stage. Prior to founding Seqster, Dana honed his skills at Abbott Laboratories, OrthoClinical Diagnostics (Johnson & Johnson), and Sequenom where he held executive and management positions in business development, sales, and marketing.

Dana received both his BS in Biochemistry and Genetics and MBA from the University of British Columbia.